Hongli Chen

Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA-CAR-T cell therapy: A retrospective study based on LEGEND-2.

The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA-CAR-T cell therapy: A retrospective study based on LEGEND-2.

Journal: HemaSphere

Published: July 03, 2024

Single-center experience of venetoclax combined with azacitidine in young patients with newly diagnosed acute myeloid leukemia.

Single-center experience of venetoclax combined with azacitidine in young patients with newly diagnosed acute myeloid leukemia.

Journal: Therapeutic advances in hematology

Published: May 20, 2024

Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis.

Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis.

Journal: Journal of healthcare engineering

Published: May 30, 2022

PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib.

PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib.

Journal: Frontiers in oncology

Published: March 23, 2021

Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia.

Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia.

Journal: Acta haematologica

Published: January 11, 2021

CD138- multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient.

CD138- multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient.

Journal: Aging

Published: January 08, 2020

miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells.

miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells.

Journal: Cell biology international

Published: December 09, 2019

Management of cytokine release syndrome related to CAR-T cell therapy.

Management of cytokine release syndrome related to CAR-T cell therapy.

Journal: Frontiers of medicine

Published: May 19, 2019

Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens.

Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 21, 2019

Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family.

Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: December 04, 2017

Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma.

Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma.

Journal: Life sciences

Published: October 03, 2017

Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformatics.

Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformatics.

Journal: Cancer science

Published: April 24, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026